Qube Research & Technologies Ltd - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 69 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q2 2024$32,956
+119.9%
1,925
+115.8%
0.00%
Q1 2024$14,986
-98.8%
892
-98.9%
0.00%
-100.0%
Q4 2022$1,249,280
+185.9%
84,525
+144.3%
0.01%
+133.3%
Q2 2022$437,000
-64.2%
34,598
-46.5%
0.00%
-70.0%
Q1 2022$1,222,000
+222.4%
64,612
+382.1%
0.01%
+66.7%
Q1 2021$379,000
+9.5%
13,402
-30.9%
0.01%
-97.4%
Q3 2019$346,000
-21.4%
19,395
-3.0%
0.23%
+119.0%
Q2 2019$440,00020,0000.10%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q1 2023
NameSharesValueWeighting ↓
AIA Investment Management Private Ltd 373,102$11,409,0003.48%
Capital International Sarl 577,755$17,668,0002.21%
Capital International, Inc./CA/ 460,082$14,069,0001.67%
Prince Street Capital Management LLC 81,400$2,489,0001.02%
Bellevue Group AG 598,310$18,296,0001.01%
CAPITAL GUARDIAN TRUST CO 1,911,064$58,359,0000.78%
PRUDENTIAL PLC 4,374,096$133,760,0000.48%
CAPITAL INTERNATIONAL LTD /CA/ 38,037$1,163,0000.28%
AIA Group Ltd 4,800$142,0000.24%
OppenheimerFunds, Inc. 4,207,823$128,675,0000.16%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders